Fueled by persistent obesity rates, rising kidney stone prevalence, and an expanding aging population, the US urological device market will grow steadily through 2034. Growth will be supported by increasing demand for BPH devices\u2014particularly Aquablation\u2014single-use endoscopes, and UI devices. The ongoing shift toward value-based care also favors the adoption of minimally invasive urological treatments that reduce hospital stay and recovery time. However, the demand for select product categories, such as Foley catheters, will be curbed by infection concerns, while urethral bulking agent procedures continue to face competition from physician-favored sling techniques. Moreover, prolonged safety concerns and past litigation will restrain genitourinary mesh device sales in the US market.<\/p>\n
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for urological devices in the US from 2019 through 2034.<\/p>\n
Single-use endoscopes have been rapidly gaining adoption.<\/b><\/p>\n
What factors are driving the rapid adoption of single-use endoscopes in the US urological device market?<\/p>\n
Who are the leading competitors in the single-use endoscopy market?<\/p>\n
How do the sales volumes of single-use endoscopes compare to those of reusable endoscopes?<\/p>\n
What are the key advantages offered by single-use endoscopes over reusable alternatives?<\/p>\n
Minimally invasive treatment volumes will grow strongly.<\/strong><\/p>\n What factors contribute to the increase of minimally invasive treatments?<\/p>\n How have minimally invasive treatment options changed the BPH<\/abbr> device market?<\/p>\n Which market segments will see the greatest adoption of minimally invasive treatments?<\/p>\n What is the impact of Aquablation on the US urological device market?<\/p>\n Mergers and acquisitions have been altering the competitive landscape.<\/b><\/p>\n What are the most relevant recent acquisitions to affect the market?<\/p>\n How will market shares and product portfolios be affected as a result of these acquisitions?<\/p>\n Ongoing clinical studies and research continue to affect procedure trends, and thus device trends.<\/strong><\/p>\n What do recent studies indicate regarding the outlook of existing techniques for treating prostate cancer, kidney stones, and BPH<\/abbr>?<\/p>\n What upcoming novel treatments are expected to compete with existing methods of treatment?<\/p>\n The UI<\/abbr> device segment represents a significant proportion of overall market revenues.<\/strong><\/p>\n What factors impact the use of UI<\/abbr> devices?<\/p>\n Some market segments are being negatively impacted by product safety concerns<\/b>.<\/strong><\/p>\n Which market segments are being impacted by safety concerns?<\/p>\n","protected":false},"template":"","class_list":["post-194461","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-urological-devices","medtech-therapy-area-urology","medtech-geography-united-states","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/194461","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":3,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/194461\/revisions"}],"predecessor-version":[{"id":572477,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/194461\/revisions\/572477"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=194461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}